Sonnet BioTherapeutics Holdings, Inc. (SONN) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 1.32M | 3.26M | 6.73M | 2.12M | 5.13M | 5.22M | 4.62M | 4.74M | 9.63M | 13.05M | 4.6M | 5.41M |
| Cash & Short-Term Investments | 321.3K | 2.06M | 4.86M | 149.46K | 3.55M | 3.79M | 3.02M | 2.27M | 7.02M | 11.39M | 1.7M | 3.05M |
| Cash Only | 321.3K | 2.06M | 4.86M | 149.46K | 3.55M | 3.79M | 3.02M | 2.27M | 7.02M | 11.39M | 1.7M | 3.05M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 597.39K | 778.19K | 666.79K | 762.08K | 519.61K | 377.96K | 194.11K | 786.57K | 749.17K | 447.01K | 1.34M | 0 |
| Days Sales Outstanding | - | - | 243.38 | - | - | - | 3.8K | 7.71K | 7.42K | 4.48K | 13.09K | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 400.88K | 420.69K | 1.2M | 0 | 1.05M | 1.06M | 1.41M | 1.68M | 1.86M | 1.21M | 0 | 2.36M |
| Total Non-Current Assets | 735.77K | 578.27K | 456.86K | 653.09K | 669.03K | 686.43K | 713.94K | 691.25K | 401.89K | 265.5K | 344.71K | 416.08K |
| Property, Plant & Equipment | 77.49K | 99.65K | 121.75K | 143.94K | 165.55K | 186.59K | 207.08K | 227.06K | 246.52K | 265.5K | 284.37K | 302.81K |
| Fixed Asset Turnover | - | - | 8.21x | - | - | - | 0.09x | 0.16x | 0.15x | 0.14x | 0.13x | 0.21x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 658.28K | 478.62K | 335.12K | 509.15K | 503.48K | 499.84K | 506.86K | 464.19K | 155.37K | -265.5K | 60.34K | 113.28K |
| Total Assets | 2.06M | 3.84M | 7.18M | 2.77M | 5.8M | 5.91M | 5.34M | 5.43M | 10.03M | 13.31M | 4.94M | 5.83M |
| Asset Turnover | - | - | 0.14x | - | - | - | 0.00x | 0.01x | 0.00x | 0.00x | 0.01x | 0.01x |
| Asset Growth % | -64.54% | -35.08% | 34.55% | -48.96% | -42.23% | -55.61% | 7.99% | -6.87% | 33.98% | -11.53% | -76.17% | -79.89% |
| Total Current Liabilities | 5.1M | 3.17M | 3.12M | 3.21M | 3.11M | 2.76M | 2.65M | 5.52M | 6.47M | 7.77M | 8.29M | 8.16M |
| Accounts Payable | 3.75M | 1.75M | 1.64M | 2.18M | 1.88M | 1.75M | 1.66M | 2.2M | 3.02M | 4.5M | 4.57M | 4.75M |
| Days Payables Outstanding | 61.77K | 28.83K | 26.97K | 36.89K | 32.6K | 31.21K | 30.25K | 41.29K | 58.17K | 87.03K | 90.56K | 96.75K |
| Short-Term Debt | 0 | 0 | 0 | 0 | 81.35K | 78.49K | 75.73K | 73.05K | 70.45K | 748 | 748 | 748 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 18.63K | 55.88K | 92.73K | 129.18K | 166.43K |
| Other Current Liabilities | 1.28M | 1.66K | 157.25K | 151.63K | 879.05K | 728.09K | 705.83K | 2.02M | 2.07M | 984.87K | 1.55M | 1.98M |
| Current Ratio | 0.26x | 1.03x | 2.15x | 0.66x | 1.65x | 1.89x | 1.74x | 0.86x | 1.49x | 1.68x | 0.55x | 0.66x |
| Quick Ratio | 0.26x | 1.03x | 2.15x | 0.66x | 1.65x | 1.89x | 1.74x | 0.86x | 1.49x | 1.68x | 0.55x | 0.66x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 0 | 0 | 23.63K | 46.57K | 68.84K | 90.45K | 110.96K | 130.86K | 150.19K | 168.94K | 186.69K | 203.91K |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 0 | 23.63K | 46.57K | 68.84K | 90.45K | 110.96K | 130.86K | 150.19K | 168.94K | 186.69K | 203.91K |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 5.1M | 3.17M | 3.15M | 3.26M | 3.18M | 2.86M | 2.77M | 5.66M | 6.62M | 7.94M | 8.48M | 8.37M |
| Total Debt | 68.84K | 90.45K | 110.96K | 130.86K | 150.19K | 168.94K | 186.69K | 203.91K | 220.63K | 237.61K | 238.79K | 255.99K |
| Net Debt | -252.46K | -1.97M | -4.75M | -18.59K | -3.4M | -3.62M | -2.83M | -2.07M | -6.8M | -11.15M | -1.46M | -2.8M |
| Debt / Equity | - | 0.14x | 0.03x | - | 0.06x | 0.06x | 0.07x | - | 0.06x | 0.04x | - | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | - | - | - | - | - | - | - | - | - | - | - | -126.37x |
| Total Equity | -3.05M | 662.26K | 4.04M | -485.74K | 2.62M | 3.05M | 2.57M | -225.98K | 3.42M | 5.37M | -3.54M | -2.54M |
| Equity Growth % | -216.36% | -78.32% | 56.91% | -114.95% | -23.41% | -43.11% | 172.73% | 91.1% | 347.32% | -37.09% | -121.58% | -111.4% |
| Book Value per Share | -0.77 | 0.17 | 2.00 | -0.75 | 4.16 | 5.29 | 5.42 | -1.03 | 20.48 | 57.22 | -89.96 | -99.76 |
| Total Shareholders' Equity | -3.05M | 662.26K | 4.04M | -485.74K | 2.62M | 3.05M | 2.57M | -225.98K | 3.42M | 5.37M | -3.54M | -2.54M |
| Common Stock | 333 | 312 | 300 | 65 | 522 | 311 | 307 | 175 | 3.84K | 2.05K | 796 | 554 |
| Retained Earnings | -128.11M | -124.33M | -120.84M | -117.68M | -114.55M | -111.05M | -111.41M | -110.24M | -106.57M | -102.62M | -96.95M | -91.41M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |